Literature DB >> 24467997

Do anxiety symptoms predict major depressive disorder in midlife women? The Study of Women's Health Across the Nation (SWAN) Mental Health Study (MHS).

H M Kravitz1, L L Schott2, H Joffe3, J M Cyranowski4, J T Bromberger5.   

Abstract

BACKGROUND: In women, anxiety symptoms are common and increase during midlife, but little is known about whether these symptoms predict onsets of major depressive disorder (MDD) episodes. We examined whether anxiety symptoms are associated with subsequent episodes of MDD in midlife African-American and Caucasian women, and whether they confer a different risk for first versus recurrent MDD episodes.
METHOD: A longitudinal analysis was conducted using 12 years of data from the Study of Women's Health Across the Nation (SWAN) Mental Health Study (MHS). The baseline sample comprised 425 Caucasian (n=278) and African American (n=147) community-dwelling women, aged 46.1±2.5 years. Anxiety symptoms measured annually using a self-report questionnaire were examined in relation to MDD episodes in the subsequent year, assessed with the SCID. Multivariable models were estimated with random effects logistic regression.
RESULTS: Higher anxiety symptoms scores were associated with a significantly higher adjusted odds of developing an episode of MDD at the subsequent annual visit [odds ratio (OR) 1.47, p=0.01], specifically for a recurrent episode (OR 1.49, p=0.03) but non-significant for a first episode (OR 1.32, p=0.27). There were no significant racial effects in the association between anxiety symptoms and subsequent MDD episodes.
CONCLUSIONS: Anxiety symptoms often precede MDD and may increase the vulnerability of midlife women to depressive episodes, particularly recurrences. Women with anxiety symptoms should be monitored clinically during the ensuing year for the development of an MDD episode.

Entities:  

Mesh:

Year:  2014        PMID: 24467997      PMCID: PMC4135380          DOI: 10.1017/S0033291714000075

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  29 in total

1.  Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN).

Authors:  Joyce T Bromberger; Laura L Schott; Howard M Kravitz; Maryfran Sowers; Nancy E Avis; Ellen B Gold; John F Randolph; Karen A Matthews
Journal:  Arch Gen Psychiatry       Date:  2010-06

2.  Does risk for anxiety increase during the menopausal transition? Study of women's health across the nation.

Authors:  Joyce T Bromberger; Howard M Kravitz; Yuefang Chang; John F Randolph; Nancy E Avis; Ellen B Gold; Karen A Matthews
Journal:  Menopause       Date:  2013-05       Impact factor: 2.953

3.  Effects of anxiety on the long-term course of depressive disorders.

Authors:  William Coryell; Jess G Fiedorowicz; David Solomon; Andrew C Leon; John P Rice; Martin B Keller
Journal:  Br J Psychiatry       Date:  2011-10-07       Impact factor: 9.319

4.  Why do people with anxiety disorders become depressed? A prospective-longitudinal community study.

Authors:  H U Wittchen; R C Kessler; H Pfister; M Lieb
Journal:  Acta Psychiatr Scand Suppl       Date:  2000

Review 5.  The importance of anxiety in both major depression and bipolar disorder.

Authors:  David Goldberg; Jan Fawcett
Journal:  Depress Anxiety       Date:  2012-05-02       Impact factor: 6.505

6.  Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN).

Authors:  J T Bromberger; H M Kravitz; Y-F Chang; J M Cyranowski; C Brown; K A Matthews
Journal:  Psychol Med       Date:  2011-02-09       Impact factor: 7.723

7.  Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population.

Authors:  Bernd Löwe; Oliver Decker; Stefanie Müller; Elmar Brähler; Dieter Schellberg; Wolfgang Herzog; Philipp Yorck Herzberg
Journal:  Med Care       Date:  2008-03       Impact factor: 2.983

Review 8.  Women and major depressive disorder: clinical perspectives on causal pathways.

Authors:  Eynav Elgavish Accortt; Marlene P Freeman; John J B Allen
Journal:  J Womens Health (Larchmt)       Date:  2008-12       Impact factor: 2.681

9.  The experience of symptoms of depression in men vs women: analysis of the National Comorbidity Survey Replication.

Authors:  Lisa A Martin; Harold W Neighbors; Derek M Griffith
Journal:  JAMA Psychiatry       Date:  2013-10       Impact factor: 21.596

10.  Gender and age-specific first incidence of DSM-III-R psychiatric disorders in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS).

Authors:  Rob V Bijl; Ron De Graaf; Anneloes Ravelli; Filip Smit; Wilma A M Vollebergh
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2002-08       Impact factor: 4.328

View more
  10 in total

Review 1.  Perimenopause: From Research to Practice.

Authors:  Nanette Santoro
Journal:  J Womens Health (Larchmt)       Date:  2015-12-10       Impact factor: 2.681

Review 2.  Menopausal Symptoms and Their Management.

Authors:  Nanette Santoro; C Neill Epperson; Sarah B Mathews
Journal:  Endocrinol Metab Clin North Am       Date:  2015-09       Impact factor: 4.741

3.  Sleep Trajectories Before and After the Final Menstrual Period in The Study of Women's Health Across the Nation (SWAN).

Authors:  Howard M Kravitz; Imke Janssen; Joyce T Bromberger; Karen A Matthews; Martica H Hall; Kristine Ruppert; Hadine Joffe
Journal:  Curr Sleep Med Rep       Date:  2017-08-05

4.  Risk factors for major depression during midlife among a community sample of women with and without prior major depression: are they the same or different?

Authors:  J T Bromberger; L Schott; H M Kravitz; H Joffe
Journal:  Psychol Med       Date:  2014-11-24       Impact factor: 7.723

5.  Symptom Clusters and Key Symptoms Among Midlife Perimenopausal and Postmenopausal Women With and Without Metabolic Syndrome.

Authors:  Se Hee Min; Qing Yang; Sharron L Docherty; Eun-Ok Im; Xiao Hu
Journal:  Nurs Res       Date:  2022-03-04       Impact factor: 2.364

6.  Correlation of Menopausal Symptoms with Serum Estradiol: A Study in Urban Indian Postmenopausal Women.

Authors:  Renuka Malik; Chanderkala Pokeria; Swati Singh
Journal:  J Obstet Gynaecol India       Date:  2021-07-12

7.  Secondary depression in severe anxiety disorders: a population-based cohort study in Denmark.

Authors:  Sandra M Meier; Liselotte Petersen; Manuel Mattheisen; Ole Mors; Preben B Mortensen; Thomas M Laursen
Journal:  Lancet Psychiatry       Date:  2015-05-14       Impact factor: 27.083

Review 8.  Sex differences in anxiety and depression clinical perspectives.

Authors:  Margaret Altemus; Nilofar Sarvaiya; C Neill Epperson
Journal:  Front Neuroendocrinol       Date:  2014-06-02       Impact factor: 8.606

9.  Analysis of Sociodemographic, Psychological, and Genetic Factors Contributing to Depressive symptoms in Pre-, Peri- and Postmenopausal Women.

Authors:  Elżbieta Grochans; Małgorzata Szkup; Artur Kotwas; Jacek Kopeć; Beata Karakiewicz; Anna Jurczak
Journal:  Int J Environ Res Public Health       Date:  2018-04-10       Impact factor: 3.390

Review 10.  Are there differences in symptoms experienced by midlife climacteric women with and without metabolic syndrome? A scoping review.

Authors:  Se Hee Min; Qing Yang; Se Won Min; Leila Ledbetter; Sharron L Docherty; Eun-Ok Im; Sharron Rushton
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.